MedTrace Logo

FLT PET Imaging for Cervical Cancer

NCT01075412 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2017-12-02

Study results available
· View outcomes & findings →

Summary

Our primary hypothesis is that \[18F\]FLT PET can identify active bone marrow in addition to metabolically active tumor.

This trial will use FLT-PET imaging to define areas of active bone marrow in the pelvis. The radiation plan is then designed to spare that area, in hopes of keeping the bone marrow active during therapy. Bone marrow and tumor activity will be monitored using a sequence of FLT PET scans during the course of chemotherapy and radiation therapy.

Conditions

  • Uterine Cervical Neoplasms

Interventions

DRUG

[F18]Fluorothymidine

FLT PET scan 5 mCi (+/- 10%)

Sponsors & Collaborators

  • Holden Comprehensive Cancer Center

    collaborator OTHER

  • University of Iowa

    lead OTHER

Principal Investigators

  • Michael M Graham, Ph.D., M.D. · University of Iowa

  • Sarah McGuire, Ph.D. · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2016-03-03
Completion
2016-04-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01075412 on ClinicalTrials.gov